Azithromycin Dihydrate Tablet, Film Coated
NDC Package 70518-4160-2
Package Information
Azithromycin Dihydrate tablets is azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. This formulation utilizes a tablet, film coated delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4160 and is authorized under FDA application ANDA208250.
Identification & Billing
- RxCUI: 308460 - azithromycin 250 MG Oral Tablet
- RxCUI: 749783 - {6 (azithromycin 250 MG Oral Tablet) } Pack
- RxCUI: 749783 - azithromycin 250 MG Oral Tablet 6 Count Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70518 - Remedyrepack Inc.
- 70518-4160 - Azithromycin Dihydrate
- 70518-4160-2 - 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 70518-4160 - Azithromycin Dihydrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70518-4160). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70518-4160-2 identifies a specific commercial package of 6 tablet, film coated in 1 bottle, plastic of Azithromycin Dihydrate, a human prescription drug labeled by Remedyrepack Inc.. This tablet, film coated is formulated for oral use and contains azithromycin dihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on August 15, 2024. The current certification is valid through December 31, 2027.
How is this Remedyrepack Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518416002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.